Evidence map›Paper›PMID 16760252›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Calcium-sensing receptor abrogates secretagogue- induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction.

John Geibel, Kumudesh Sritharan, Rainer Geibel, Peter Geibel, J Scott Persing, Achim Seeger, Torsten K Roepke, Markus Deichstetter, Christian Prinz, Sam X Cheng and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 132 citations in OpenAlex.

  1. A Sustainable Hybrid (NHLuminescence : the journal of biological and chemical luminescence · 2026
    Article
  2. Coupling MgSOScientific reports · 2026
    Article
  3. Lactobacillus johnsonii Generates Cyclo(pro-trp) and Promotes Intestinal CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Review
  5. Repurposing calcium-sensing receptor activator drug cinacalcet for ADPKD treatment.Translational research : the journal of laboratory and clinical medicine · 2024
    Article
  6. Calcium/calcimimeticWorld journal of gastroenterology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Salinity-dependent expression of calcium-sensing receptors in Atlantic salmon (Salmo salar) tissues.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

John GeibelDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. john.geibel@yale.edu
Kumudesh Sritharan
Rainer Geibel
Peter Geibel
J Scott Persing
Achim Seeger
Torsten K Roepke
Markus Deichstetter
Christian Prinz
Sam X Cheng
David Martin
Steven C Hebert
Amgen (United States) · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The calcium-sensing receptor (CaSR) provides a fundamental mechanism for diverse cells to detect and respond to modulations in the ionic and nutrient compositions of their extracellular milieu. The roles for this receptor are largely unknown in the intestinal tract, where epithelial cells are normally exposed to large variations in extracellular solutes. Here, we show that colonic CaSR signaling stimulates the degradation of cyclic nucleotides by phosphodiesterases and describe the ability of receptor activation to reverse the fluid and electrolyte secretory actions of cAMP- and cGMP-generating secretagogues, including cholera toxin and heat stable Escherichia coli enterotoxin STa. Our results suggest a paradigm for regulation of intestinal fluid transport where fine tuning is accomplished by the counterbalancing effects of solute activation of the CaSR on neuronal and hormonal secretagogue actions. The reversal of cholera toxin- and STa endotoxin-induced fluid secretion by a small-molecule CaSR agonist suggests that these compounds may provide a unique therapy for secretory diarrheas.

Indexed as

Aniline CompoundsAnimalsBacterial ToxinsCalciumCations, DivalentIntestinal SecretionsMaleMiceMice, KnockoutNucleotides, CyclicPhenethylaminesPhosphoric Diester HydrolasesPropylaminesRatsReceptors, Calcium-SensingType C PhospholipasesAniline CompoundsBacterial ToxinsCalciumCations, DivalentN-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamineNucleotides, CyclicPhenethylaminesPhosphoric Diester HydrolasesPropylaminesReceptors, Calcium-SensingType C Phospholipases

Identifiers

PMID16760252
PMCPMC1475505
OpenAlexW2118207659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.